{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:37:06Z","timestamp":1789994226774,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T00:00:00Z","timestamp":1164153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T00:00:00Z","timestamp":1164153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00417-006-0460-x","type":"journal-article","created":{"date-parts":[[2006,11,21]],"date-time":"2006-11-21T13:16:28Z","timestamp":1164114988000},"page":"825-833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Ocular penetration of caspofungin in a rabbit uveitis model"],"prefix":"10.1007","volume":"245","author":[{"given":"David","family":"Goldblum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Fausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice E.","family":"Frueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regula","family":"Theurillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Thormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Zimmerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,11,22]]},"reference":[{"key":"460_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1128\/AAC.46.2.451-457.2002","volume":"46","author":"EG Arathoon","year":"2002","unstructured":"Arathoon EG, Gotuzzo E, Noriega LM, Berman RS, DiNubile MJ, Sable CA (2002) Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother 46:451\u2013457","journal-title":"Antimicrob Agents Chemother"},{"key":"460_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ajo.2004.08.077","volume":"139","author":"SM Breit","year":"2005","unstructured":"Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG (2005) Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol 139:135\u2013140","journal-title":"Am J Ophthalmol"},{"key":"460_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0378-4347(98)00447-2","volume":"721","author":"CM Chavez-Eng","year":"1999","unstructured":"Chavez-Eng CM, Schwartz M, Constanzer ML, Matuszewski BK (1999) Determination of a cyclic hexapeptide, a novel antifungal agent, in human plasma by high-performance liquid chromatography with ion spray and turbo ion spray tandem mass spectrometric detection. J Chromatogr B Biomed Sci Appl 721:229\u2013238","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"Suppl 3","key":"460_CR4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1439-0507.2002.tb04771.x","volume":"45","author":"OA Cornely","year":"2002","unstructured":"Cornely OA, Schmitz K, Aisenbrey S (2002) The first echinocandin: caspofungin. Mycoses 45(Suppl)3:56\u201360","journal-title":"Mycoses"},{"key":"460_CR5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","volume":"362","author":"DW Denning","year":"2003","unstructured":"Denning DW (2003) Echinocandin antifungal drugs. Lancet 362:1142\u20131151","journal-title":"Lancet"},{"key":"460_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ajo.2005.03.030","volume":"140","author":"ML Durand","year":"2005","unstructured":"Durand ML, Kim IK, D\u2019Amico DJ, Loewenstein JI, Tobin EH, Kieval SJ, Martin SS, Azar DT, Miller FS 3rd, Lujan BJ, Miller JW (2005) Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin. Am J Ophthalmol 140:552\u2013554","journal-title":"Am J Ophthalmol"},{"key":"460_CR7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/infdis\/169.2.356","volume":"169","author":"P Francis","year":"1994","unstructured":"Francis P, Lee JW, Hoffman A, Peter J, Francesconi A, Bacher J, Shelhamer J, Pizzo PA, Walsh TJ (1994) Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar d-mannitol and serum galactomannan as markers of infection. J Infect Dis 169:356\u2013368","journal-title":"J Infect Dis"},{"key":"460_CR8","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1086\/431761","volume":"41","author":"GM Gauthier","year":"2005","unstructured":"Gauthier GM, Nork TM, Prince R, Andes D (2005) Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. Clin Infect Dis 41:e27\u2013e28","journal-title":"Clin Infect Dis"},{"key":"460_CR9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1128\/AAC.49.4.1359-1363.2005","volume":"49","author":"D Goldblum","year":"2005","unstructured":"Goldblum D, Frueh BE, Sarra GM, Katsoulis K, Zimmerli S (2005) Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrob Agents Chemother 49:1359\u20131363","journal-title":"Antimicrob Agents Chemother"},{"key":"460_CR10","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1128\/AAC.46.12.3719-3723.2002","volume":"46","author":"D Goldblum","year":"2002","unstructured":"Goldblum D, Rohrer K, Frueh BE, Theurillat R, Thormann W, Zimmerli S (2002) Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model. Antimicrob Agents Chemother 46:3719\u20133723","journal-title":"Antimicrob Agents Chemother"},{"key":"460_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1128\/AAC.45.2.596-600.2001","volume":"45","author":"AH Groll","year":"2001","unstructured":"Groll AH, Gullick BM, Petraitiene R, Petraitis V, Candelario M, Piscitelli SC, Walsh TJ (2001) Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits. Antimicrob Agents Chemother 45:596\u2013600","journal-title":"Antimicrob Agents Chemother"},{"key":"460_CR12","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/AAC.41.11.2339","volume":"41","author":"R Hajdu","year":"1997","unstructured":"Hajdu R, Thompson R, Sundelof JG, Pelak BA, Bouffard FA, Dropinski JF, Kropp H (1997) Preliminary animal pharmacokinetics of the parenteral antifungal agent mk-0991 (L-743,872). Antimicrob Agents Chemother 41:2339\u20132344","journal-title":"Antimicrob Agents Chemother"},{"key":"460_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1006\/exer.1993.1036","volume":"56","author":"PS Kulkarni","year":"1993","unstructured":"Kulkarni PS, Mancino M (1993) Studies on intraocular inflammation produced by intravitreal human interleukins in rabbits. Exp Eye Res 56:275\u2013279","journal-title":"Exp Eye Res"},{"key":"460_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0039-6257(96)80004-X","volume":"41","author":"LA Levin","year":"1996","unstructured":"Levin LA, Avery R, Shore JW, Woog JJ, Baker AS (1996) The spectrum of orbital aspergillosis: a clinicopathological review. Surv Ophthalmol 41:142\u2013154","journal-title":"Surv Ophthalmol"},{"key":"460_CR15","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1128\/AAC.49.12.5058-5068.2005","volume":"49","author":"A Louie","year":"2005","unstructured":"Louie A, Deziel M, Liu W, Drusano MF, Gumbo T, Drusano GL (2005) Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity. Antimicrob Agents Chemother 49:5058\u20135068","journal-title":"Antimicrob Agents Chemother"},{"key":"460_CR16","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1056\/NEJMoa021585","volume":"347","author":"J Mora-Duarte","year":"2002","unstructured":"Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, Lupinacci R, Sable C, Kartsonis N, Perfect J (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347:2020\u20132029","journal-title":"N Engl J Med"},{"key":"460_CR17","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1128\/AAC.48.4.1272-1280.2004","volume":"48","author":"P Sandhu","year":"2004","unstructured":"Sandhu P, Xu X, Bondiskey PJ, Balani SK, Morris ML, Tang YS, Miller AR, Pearson PG (2004) Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys. Antimicrob Agents Chemother 48:1272\u20131280","journal-title":"Antimicrob Agents Chemother"},{"key":"460_CR18","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1086\/427753","volume":"40","author":"JC Sarria","year":"2005","unstructured":"Sarria JC, Bradley JC, Habash R, Mitchell KT, Kimbrough RC, Vidal AM (2005) Candida glabrata endophthalmitis treated successfully with caspofungin. Clin Infect Dis 40:e46-e48","journal-title":"Clin Infect Dis"},{"key":"460_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0003-2670(97)00263-8","volume":"352","author":"M Schwartz","year":"1997","unstructured":"Schwartz M, Kline W, Matuszewski B (1997) Determination of a cyclic hexapeptide (L-743 872), a novel pneumocandin antifungal agent in human plasma and urine by high-performance liquid chromatography with fluorescence detection. Anal Chim Acta 352:299\u2013307","journal-title":"Anal Chim Acta"},{"key":"460_CR20","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1755-3768.1991.tb02053.x","volume":"69","author":"R Srinivasan","year":"1991","unstructured":"Srinivasan R, Kanungo R, Goyal JL (1991) Spectrum of oculomycosis in south India. Acta Ophthalmol (Copenh) 69:744\u2013749","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"460_CR21","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1128\/AAC.48.9.3407-3411.2004","volume":"48","author":"DA Stevens","year":"2004","unstructured":"Stevens DA, Espiritu M, Parmar R (2004) Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 48:3407\u20133411","journal-title":"Antimicrob Agents Chemother"},{"key":"460_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.diagmicrobio.2004.10.006","volume":"51","author":"DA Stevens","year":"2005","unstructured":"Stevens DA, White TC, Perlin DS, Selitrennikoff CP (2005) Studies of the paradoxical effect of caspofungin at high drug concentrations. Diagn Microbiol Infect Dis 51:173\u2013178","journal-title":"Diagn Microbiol Infect Dis"},{"key":"460_CR23","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1128\/AAC.48.3.815-823.2004","volume":"48","author":"JA Stone","year":"2004","unstructured":"Stone JA, Xu X, Winchell GA, Deutsch PJ, Pearson PG, Migoya EM, Mistry GC, Xi L, Miller A, Sandhu P, Singh R, deLuna F, Dilzer SC, Lasseter KC (2004) Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma. Antimicrob Agents Chemother 48:815\u2013823","journal-title":"Antimicrob Agents Chemother"},{"key":"460_CR24","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1086\/323401","volume":"33","author":"A Villanueva","year":"2001","unstructured":"Villanueva A, Arathoon EG, Gotuzzo E, Berman RS, DiNubile MJ, Sable CA (2001) A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis. Clin Infect Dis 33:1529\u20131535","journal-title":"Clin Infect Dis"},{"key":"460_CR25","first-page":"467","volume":"38","author":"TJ Walsh","year":"1988","unstructured":"Walsh TJ, Bacher J, Pizzo PA (1988) Chronic silastic central venous catheterization for induction, maintenance and support of persistent granulocytopenia in rabbits. Lab Anim Sci 38:467\u2013471","journal-title":"Lab Anim Sci"},{"key":"460_CR26","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMoa040446","volume":"351","author":"TJ Walsh","year":"2004","unstructured":"Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE (2004) Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med 351:1391\u20131402","journal-title":"N Engl J Med"},{"key":"460_CR27","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1086\/424465","volume":"190","author":"NP Wiederhold","year":"2004","unstructured":"Wiederhold NP, Kontoyiannis DP, Chi J, Prince RA, Tam VH, Lewis RE (2004) Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. J Infect Dis 190:1464\u20131471","journal-title":"J Infect Dis"},{"key":"460_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0039-6257(05)80041-4","volume":"39","author":"RA Yohai","year":"1994","unstructured":"Yohai RA, Bullock JD, Aziz AA, Markert RJ (1994) Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 39:3\u201322","journal-title":"Surv Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0460-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-006-0460-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0460-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-006-0460-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T21:49:58Z","timestamp":1652824198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-006-0460-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,22]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["460"],"URL":"https:\/\/doi.org\/10.1007\/s00417-006-0460-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,22]]},"assertion":[{"value":"26 May 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}